Nelly Robillard
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Transplantation top 1%
Papers in
- Hematology 50
- Multiple Myeloma Research and Treatments 39
-
- Glycosylation and Glycoproteins Research 16
- Co-authors
- Régis Bataille (32 shared papers)Martine Amiot (20 shared papers)Philippe Moreau (22 shared papers)Catherine Pellat‐Deceunynck (19 shared papers)Hervé Avet‐Loiseau (18 shared papers)Jean‐Luc Harousseau (14 shared papers)Danielle Pineau (12 shared papers)Gaëtan Jégo (8 shared papers)
In The Last Decade
Nelly Robillard
93 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 119
- Hematology 1.7k
- Transplantation 292
- Genetics 641
- Immunology 1.1k
- Oncology 1.2k
Countries citing papers authored by Nelly Robillard
This map shows the geographic impact of Nelly Robillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelly Robillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelly Robillard more than expected).
Fields of papers citing papers by Nelly Robillard
This network shows the impact of papers produced by Nelly Robillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelly Robillard. The network helps show where Nelly Robillard may publish in the future.
Co-authors
The 25 scholars most cited alongside Nelly Robillard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 272 | |
| 2 | 2006 | 219 | |
| 3 | 1990 | 208 | |
| 4 | 2007 | 203 | |
| 5 | 1994 | 175 | |
| 6 | The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy. | 2006 | 171 |
| 7 | 1999 | 170 | |
| 8 | 1998 | 136 | |
| 9 | 1999 | 134 | |
| 10 | 2003 | 130 | |
| 11 | 1999 | 115 | |
| 12 | 2004 | 104 | |
| 13 | 2002 | 99 | |
| 14 | 2004 | 89 | |
| 15 | CD28, a marker associated with tumoral expansion in multiple myeloma. | 1998 | 80 |
| 16 | 2002 | 64 | |
| 17 | Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma. | 2004 | 59 |
| 18 | 2014 | 56 | |
| 19 | 2005 | 52 | |
| 20 | 1999 | 51 |
About Nelly Robillard
Nelly Robillard is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Genetics, having authored 94 papers that have together received 3.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (39 papers), Chronic Lymphocytic Leukemia Research (16 papers), Glycosylation and Glycoproteins Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers), Acute Lymphoblastic Leukemia research (12 papers), Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Hematology (1.7k citations), Transplantation (292 citations), Genetics (641 citations), Immunology (1.1k citations) and Oncology (1.2k citations). Nelly Robillard has collaborated with scholars based in France, Canada and Belgium. Frequent co-authors include Régis Bataille, Martine Amiot, Philippe Moreau, Catherine Pellat‐Deceunynck, Hervé Avet‐Loiseau, Jean‐Luc Harousseau, Danielle Pineau, Gaëtan Jégo, Richard Garand and Denis Puthier. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Leukemia Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.